Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT07029243
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cirrhosis
- Frailty
- Sarcopenia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- HEAL-ME digital app — BEHAVIORALHEAL-ME is a digital prehabilitation app that provides semi-guided nutrition/exercise prehabilitation
- Creatine supplementation — DIETARY_SUPPLEMENTPatients will take 5g creatine supplementation daily for 13 weeks
- Whey protein supplementation — DIETARY_SUPPLEMENTPatients will take 35g whey protein supplementation daily
- Placebo — DIETARY_SUPPLEMENTPatients will be administered daily placebo supplementation.
Study Details
Frailty and muscle health are important for patients with chronic liver disease. This study looks at the use of a digital prehabilitation app (HEAL-ME) plus creatine and whey protein combination supplementation on maintaining muscle health in patients with liver disease. The investigators anticipate that this combination of supplementation and nutrition/exercise prehabilitation app will maintain muscle health in patients with liver disease.
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Placebo Comparator: HEAL-ME and placebo supplementationPatients within this arm will be administered the HEAL-ME digital app and placebo supplementation daily
- Experimental: HEAL-ME and creatine/whey protein supplementationPatients within this arm will be administered the HEAL-ME digital app and whey protein/creatine combination supplementation daily
Primary Outcome Measure
Frailty [ Time Frame: From enrollment to end of study at 12 weeks ]
Central Contacts
- Melinda Wang, MD, MHS415-476-2777
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94143 | Jennifer Lai, MD, MBA (PRINCIPAL_INVESTIGATOR) Melinda Wang, MD, MHS (SUB_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- Identifying Modifiable PAtient Centered Therapeutics (IMPACT) FrailtyRecruiting · University of California, Los Angeles · Los Angeles, California
- Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434PHASE1 · Recruiting · Vir Biotechnology, Inc. · Rialto, California
- Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIRecruiting · VA Office of Research and Development · Birmingham, Alabama
- An Observational Study of Patients With Chronic Liver DiseaseEnrolling By Invitation · Target PharmaSolutions, Inc. · Los Angeles, California